This is a modest but conviction insider buy from a 10% owner, which is a positive signal. A score of 5 avoids overconfidence. Monitor for any subsequent insider buying or a pending catalyst (e.g., partnership, FDA news).
Price Chart
Executive Summary
A 10% owner of CapsoVision, Eliyhou Harari, purchased $102K of CV stock on June 26, 2026, at $7.35/share. This is a single, mid-value insider buy representing ~0.03% of the company's $330M market cap. Harari is a key insider (beneficial owner), and the purchase is a modest but notable bullish signal, given that CV has been a strong performer historically for the model and analyst consensus is 89% bullish.
Key Financial Metrics
Key Facts
- 10% owner Eliyhou Harari purchased 13,800 shares of CV at $7.35 for total consideration of $102,457.
- Transaction date: June 26, 2026.
- Purchase represents approximately 0.031% of CV's $330M market capitalization.
- CapsoVision operates in the Electromedical & Electrotherapeutic Apparatus sector (Nasdaq).
- Analyst consensus is 89% bullish (3 Strong Buy, 5 Buy, 1 Hold).
Financial Impact
$102K open-market purchase, 0.03% of market cap
Risk Factors
- The purchase is a small fraction of market cap (0.031%), limiting its informational impact.
- 10% owner buying may be linked to a private arrangement or control-related strategy rather than a pure view of undervaluation.
- No other insiders joined the purchase, reducing cluster signal strength.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001009165-26-000004 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | 8-K | $6.92 | awaiting T+60 | — | $6.88 (−0.58%) |
Sep 28, 2026 28d ago | Press Release | $6.92 | awaiting T+60 | — | $6.88 (−0.58%) |
Sep 23, 2026 4w ago | Insider Cluster | $6.17 | awaiting T+60 | — | $6.88 (+11.51%) |
Sep 22, 2026 4w ago | Institutional Cluster | $6.30 | awaiting T+60 | — | $6.88 (+9.21%) |
Sep 18, 2026 5w ago | 424B5 | $6.70 | awaiting T+60 | — | $6.88 (−2.69%) |
Aug 24, 2026 9w ago | EFFECT | $5.83 | awaiting T+60 | — | $6.88 (−18.01%) |
Aug 13, 2026 10w ago | S-3 | $6.46 | awaiting T+60 | — | $6.88 (−6.50%) |
Jul 21, 2026 13w ago | Insider Buy | $6.91 $6.45 | ▼ −6.66% | ▼ −9.92% | $6.88 (−0.43%) |
Jul 10, 2026 15w ago | Insider Buy | $6.22 $6.50 | ▲ +4.50% | ▲ +0.51% | $6.88 (+10.61%) |
Jul 7, 2026 15w ago | Insider Buy | $6.13 $6.32 | ▲ +3.18% | ▲ +0.69% | $6.88 (+12.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers